Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Cancer Medicine|December 30, 2022
Circulating gamma-glutamyl transpeptidase and risk of pancreatic cancer: A prospective cohort study in the UK BiobankWeiting Liao, Yu Yang, Huazhen Yang, et al.Oral Oncology|May 20, 2020
Pembrolizumab alone or with chemotherapy for squamous cell carcinoma of the head and neck: A cost-effectiveness analysis from Chinese perspectiveKexun Zhou, Yunzhu Li, Weiting Liao, et al.Experimental Eye Research|February 16, 2025
Palmitic acid exacerbates experimental autoimmune uveitis by activating T helper 17 cells via regulating STING signalingXiaojie Feng, Hongmiao Wang, Zhenyu Zhong, et al.Journal of the American Academy of Dermatology|March 5, 2025
Effect of prednisone plus either adalimumab or cyclosporine on dermatological symptoms in Vogt-Koyanagi-Harada disease: Systemic outcomes from a randomized trialZhenyu Zhong, Jiayi Wang, Weiting Liao, et al.Oral Oncology|February 20, 2020
Cost-effectiveness analysis of gemcitabine plus cisplatin versus docetaxel, cisplatin and fluorouracil for induction chemotherapy of locoregionally advanced nasopharyngeal carcinomaQiuji Wu, Weiting Liao, Jiaxing Huang, et al.Rheumatology (Oxford, England)|January 12, 2022
Evaluation of sensitivity and specificity of diagnostic criteria for Behçet's disease in the absence of a gold standardZhenyu Zhong, Weiting Liao, Yu Gao, et al.Oncology Research and Treatment|March 19, 2020
Cost-Effectiveness Analysis of Bevacizumab plus Paclitaxel versus Bevacizumab plus Capecitabine for HER2-Negative Locally Recurrent or Metastatic Breast CancerQiuji Wu, Xinyuan Wang, Mengxi Zhang, et al.BMC Bioinformatics|October 19, 2022
Study on the prognosis, immune and drug resistance of m6A-related genes in lung cancerYang Yang, Zhouyao Qian, Mingyang Feng, et al.Therapeutic Advances in Medical Oncology|January 31, 2022
Cost-effectiveness of enfortumab vedotin in previously treated advanced urothelial carcinomaQiuji Wu, Yi Qin, Weiting Liao, et al.Biomedicines|July 27, 2024
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and ChallengesAntonio Cigliano, Weiting Liao, Giovanni A Deiana, et al.Pageof 6